Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study
10,000 participant randomized Phase 2b study will evaluate Gritstone’s self-amplifying mRNA (samRNA) vaccine candidate containing Spike...
top of page
A L T I T U D E
Life Science Ventures
Companies in the News
bottom of page